NMN for Age-Related Macular Degeneration: What the Evidence Actually Shows
What is Age-Related Macular Degeneration?
Age-related macular degeneration is the leading cause of central vision loss in older adults. It exists in dry (atrophic) and wet (neovascular) forms with different treatments.
NMN relevance: the published evidence
AREDS2 vitamin formulations and anti-VEGF injections have human evidence in AMD. NMN has no completed AMD trial. Mechanistic interest exists around retinal NAD+ and mitochondrial health, but clinical translation is unproven.
Questions to ask before supplementing
No dose validated in AMD.
Contraindications and red flags
Do not delay AREDS2 supplementation or anti-VEGF therapy when prescribed.
Bottom line for Malaysian patients
NMN is not registered with NPRA as a treatment for any specific condition; it is sold as a general health supplement. If you have age-related macular degeneration, use this page as a question list for a registered medical practitioner before adding NMN to existing therapy. Read our safety guide for full red-flag context.
Related conditions
- Glaucoma - Glaucoma is a group of eye diseases that damage the optic nerve, often associated with raised intrao...
- Dry Eye Disease - Dry eye disease is a chronic problem of tear film instability, causing irritation, blurred vision an...
- Age-Related Hearing Loss (Presbycusis) - Presbycusis is the gradual high-frequency hearing loss that comes with ageing, due to cochlear hair ...
- Biological Aging - Biological aging refers to the gradual decline in cellular and organ function that accompanies chron...